The knowledge of how adiponectin and leptin can interact with the androgen receptor signaling may prospectively guide the development of therapeutic approaches aimed at potentiating the inhibitory actions of adiponectin and androgen receptor or interfering with the pro-stimulatory role of leptin in BC. This evidence concerns the gene AR and breast cancer.